National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia-Reference-Cited by-同舟云学术

National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia

Published:2020-03-25 Issue:2 Volume:7 Page:161-170
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Almubark Rasha A.,Aljadani Rawabi H.,Alqahtani Amani S.,Alshammari Thamir M.,BinDhim Nasser F.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40801-020-00186-8.pdf

Reference30 articles.

1. Committee on Quality of Health Care in America. To err is human: building a safer health system. Washington, DC: National Academies Press; 2000. http://www.ncbi.nlm.nih.gov/books/NBK225182/. Accessed 22 Oct 2018.

2. World Health Organization. Safety of medicines—a guide to detecting and reporting adverse drug reactions—why health professionals need to take action. Introduction. Geneva: WHO; 2002. http://apps.who.int/medicinedocs/en/d/Jh2992e/1.html. Accessed 31 Oct 2018.

3. Shepherd G, Mohorn P, Yacoub K, et al. Adverse drug reaction deaths reported in United States: vital statistics, 1999–2006. Ann Pharmacother. 2012;46:169–75. https://doi.org/10.1345/aph.1P592.

4. Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol. 2007;7:9. https://doi.org/10.1186/1472-6904-7-9.

5. Pirmohamed M. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9. https://doi.org/10.1136/bmj.329.7456.15.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A National Survey of Community Pharmacists’ Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia;Frontiers in Pharmacology;2022-05-26

2. Patterns of adverse drug reactions (ADRs) in Saudi Arabia;Saudi Pharmaceutical Journal;2022-01

3. Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use;PLOS ONE;2021-06-10

4. Medication Misadventures Among COVID-19 Patients in Saudi Arabia;Cureus;2021-06-08

5. A population-based study of self-reported adverse drug events among Lebanese outpatients;Scientific Reports;2021-04-12